Triaging Patients With Musculoskeletal Disorders Directly to Physiotherapists at Primary Health Care Clinics.

April 25, 2019 updated by: Göteborg University

The Effects of Triaging Patients With Musculoskeletal Disorders Directly to Physiotherapists at Primary Health Care Clinics: a Pilot Study and Randomized Controlled Trial.

The purpose of this study is to determine whether initial triaging to physiotherapists of patients with musculoskeletal disorders who seek health care from primary care clinics affects the patients health and/or health care utilization differently than initial consultation with a general practitioner.

Study Overview

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gothenburg, Sweden, 417 64
        • Närhälsan Eriksberg Health centre
      • Gothenburg, Sweden, 418 33
        • Närhälsan Biskopsgården Health centre
      • Gothenburg, Sweden, 418 73
        • Närhälsan Kyrkbyn Health centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 67 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • seeking primary care clinic for musculoskeletal disorder
  • age 16-67 years
  • speaks enough Swedish or English to understand the patient information and complete the questionnaires
  • triage nurse judges it suitable to triage participant to physiotherapist

Exclusion Criteria:

  • has received treatment at the clinic by physician or physiotherapist during the preceding month for the same problem
  • seeking for chronic musculoskeletal disorder with unchanged symptoms the latest 3 months and for which the patient has already tried physiotherapy
  • seeking for help with medical aids other than crutches
  • is in need of home care
  • has been included in the study earlier

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Initially triaged to physiotherapist
Active Comparator: Initially triaged to physician

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of physician visits
Time Frame: 1 year
1 year
Change in self-evaluated level of pain latest week (0-10 scale)
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of physiotherapist visits
Time Frame: 1 year
1 year
Number of days of sick-leave
Time Frame: 1 year
1 year
Number of referrals for external examinations and to specialists
Time Frame: 1 year
1 year
Changes in health-related quality of life measured with EQ-5D
Time Frame: 2 weeks
2 weeks
Changes in health-related quality of life measured with EQ-5D
Time Frame: 3 months
3 months
Changes in health-related quality of life measured with EQ-5D
Time Frame: 6 months
6 months
Changes in health-related quality of life measured with EQ-5D
Time Frame: 1 year
1 year
Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale
Time Frame: 2 weeks
2 weeks
Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale
Time Frame: 3 months
3 months
Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale
Time Frame: 6 months
6 months
Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale
Time Frame: 1 year
1 year
Change in experience of functional difficulty measured with DRI scale
Time Frame: 2 weeks
2 weeks
Change in experience of functional difficulty measured with DRI scale
Time Frame: 3 months
3 months
Change in experience of functional difficulty measured with DRI scale
Time Frame: 6 months
6 months
Change in experience of functional difficulty measured with DRI scale
Time Frame: 1 year
1 year
Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire
Time Frame: 2 weeks
2 weeks
Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire
Time Frame: 3 months
3 months
Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire
Time Frame: 6 months
6 months
Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire
Time Frame: 1 year
1 year
Change in self-evaluated level of pain latest week (0-10 scale)
Time Frame: 2 weeks
2 weeks
Change in self-evaluated level of pain latest week (0-10 scale)
Time Frame: 6 months
6 months
Change in self-evaluated level of pain latest week (0-10 scale)
Time Frame: 1 year
1 year
Prescriptions för analgesics for the actual musculoskeletal disorder
Time Frame: 2 weeks
Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.
2 weeks
Prescriptions för analgesics for the actual musculoskeletal disorder
Time Frame: 3 months
Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.
3 months
Prescriptions för analgesics for the actual musculoskeletal disorder
Time Frame: 6 months
Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.
6 months
Prescriptions för analgesics for the actual musculoskeletal disorder
Time Frame: 1 year
Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lena Bornhöft, MSc, RPT, Göteborg University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2014

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

March 1, 2019

Study Registration Dates

First Submitted

August 15, 2014

First Submitted That Met QC Criteria

August 15, 2014

First Posted (Estimate)

August 18, 2014

Study Record Updates

Last Update Posted (Actual)

April 26, 2019

Last Update Submitted That Met QC Criteria

April 25, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 148611
  • VGFOUGSB-421881 (Other Grant/Funding Number: FoU primärvård Göteborg och Södra Bohuslän)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Disorders

Clinical Trials on Initially triaged to physiotherapist

Subscribe